463 related articles for article (PubMed ID: 31156160)
1. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
2. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
3. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-Loaded Nanocapsules Reverses the Depressant-Like Behavior and Oxidative Stress Induced by β-Amyloid in Mice.
Fidelis EM; Savall ASP; da Luz Abreu E; Carvalho F; Teixeira FEG; Haas SE; Bazanella Sampaio T; Pinton S
Neuroscience; 2019 Dec; 423():122-130. PubMed ID: 31698022
[TBL] [Abstract][Full Text] [Related]
5. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
Meng F; Asghar S; Gao S; Su Z; Song J; Huo M; Meng W; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2015 Oct; 134():88-97. PubMed ID: 26162977
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice.
Giacomeli R; Izoton JC; Dos Santos RB; Boeira SP; Jesse CR; Haas SE
Brain Res; 2019 Oct; 1721():146325. PubMed ID: 31325424
[TBL] [Abstract][Full Text] [Related]
7. Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease.
Vedagiri A; Thangarajan S
Neuropeptides; 2016 Aug; 58():111-25. PubMed ID: 27021394
[TBL] [Abstract][Full Text] [Related]
8. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
Maiti P; Paladugu L; Dunbar GL
BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
[TBL] [Abstract][Full Text] [Related]
10. Corydalis edulis total alkaloids (CETA) ameliorates cognitive dysfunction in rat model of Alzheimer disease through regulation of the antioxidant stress and MAP2/NF-κB.
Liang S; Zheng Y; Lei L; Deng X; Ai J; Li Y; Zhang T; Mei Z; Ren Y
J Ethnopharmacol; 2020 Apr; 251():112540. PubMed ID: 31917278
[TBL] [Abstract][Full Text] [Related]
11. CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease.
Jiao W; Wang Y; Kong L; Ou-Yang T; Meng Q; Fu Q; Hu Z
Biochem Biophys Res Commun; 2018 Jul; 501(4):1016-1022. PubMed ID: 29777699
[TBL] [Abstract][Full Text] [Related]
12. Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study.
Khonsari F; Heydari M; Sharifzadeh M; Valizadeh H; Dinarvand R; Atyabi F
Biomater Adv; 2022 Jun; 137():212827. PubMed ID: 35929260
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer's Disease.
ELBini-Dhouib I; Doghri R; Ellefi A; Degrach I; Srairi-Abid N; Gati A
Molecules; 2021 May; 26(10):. PubMed ID: 34070220
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
16. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
[TBL] [Abstract][Full Text] [Related]
17. Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin.
Samy DM; Ismail CA; Nassra RA; Zeitoun TM; Nomair AM
Eur J Pharmacol; 2016 Jan; 770():52-60. PubMed ID: 26638997
[TBL] [Abstract][Full Text] [Related]
18. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
19. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation.
Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M
ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941
[TBL] [Abstract][Full Text] [Related]
20. PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease.
Shahbaz SK; Koushki K; Sathyapalan T; Majeed M; Sahebkar A
Curr Neuropharmacol; 2022; 20(2):309-323. PubMed ID: 34429054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
